Handelsbanken Fonder’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.38M | Buy |
19,306
+5,200
| +37% | +$926K | 0.01% | 532 |
|
|
2026
Q1 | $2.43M | Hold |
14,106
| – | – | 0.01% | 665 |
|
|
2025
Q4 | $2.81M | Sell |
14,106
-500
| -3% | -$90.7K | 0.01% | 630 |
|
|
2025
Q3 | $2.29M | Buy |
14,606
+3,069
| +27% | +$487K | 0.01% | 683 |
|
|
2025
Q2 | $1.75M | Hold |
11,537
| – | – | 0.01% | 712 |
|
|
2025
Q1 | $1.74M | Sell |
11,537
-900
| -7% | -$151K | 0.01% | 705 |
|
|
2024
Q4 | $2.3M | Buy |
12,437
+200
| +2% | +$38.5K | 0.01% | 623 |
|
|
2024
Q3 | $2.41M | Buy |
12,237
+1,900
| +18% | +$395K | 0.01% | 602 |
|
|
2024
Q2 | $2.13M | Buy |
10,337
+1,500
| +17% | +$340K | 0.01% | 571 |
|
|
2024
Q1 | $2.39M | Hold |
8,837
| – | – | 0.01% | 557 |
|
|
2023
Q4 | $2.09M | Buy |
8,837
+200
| +2% | +$39.3K | 0.01% | 548 |
|
|
2023
Q3 | $1.69M | Buy |
8,637
+800
| +10% | +$164K | 0.01% | 581 |
|
|
2023
Q2 | $1.65M | Buy |
7,837
+800
| +11% | +$159K | 0.01% | 584 |
|
|
2023
Q1 | $1.42M | Hold |
7,037
| – | – | 0.01% | 598 |
|
|
2022
Q4 | $1.53M | Buy |
7,037
+100
| +1% | +$21.8K | 0.01% | 558 |
|
|
2022
Q3 | $1.36M | Hold |
6,937
| – | – | 0.01% | 578 |
|
|
2022
Q2 | $1.48M | Sell |
6,937
-900
| -11% | -$220K | 0.01% | 587 |
|
|
2022
Q1 | $2.23M | Hold |
7,837
| – | – | 0.01% | 564 |
|
|
2021
Q4 | $2.95M | Hold |
7,837
| – | – | 0.01% | 553 |
|
|
2021
Q3 | $3.23M | Sell |
7,837
-200
| -2% | -$83.1K | 0.02% | 542 |
|
|
2021
Q2 | $2.97M | Sell |
8,037
-1,600
| -17% | -$534K | 0.02% | 559 |
|
|
2021
Q1 | $2.79M | Hold |
9,637
| – | – | 0.02% | 545 |
|
|
2020
Q4 | $2.41M | Hold |
9,637
| – | – | 0.01% | 570 |
|
|
2020
Q3 | $2.18M | Hold |
9,637
| – | – | 0.02% | 542 |
|
|
2020
Q2 | $1.68M | Buy |
+9,637
| New | +$1.54M | 0.01% | 559 |
|
Other funds holding CRL
CIM
RP
P
CNB
MPPW
GI
EFG
QCM
VCM